Use of hyperbaric oxygenation as an adjunctive treatment for severe pernicious anaemia in a bloodless medicine patient.

What Researchers Did

Researchers reported a case where hyperbaric oxygen therapy (HBO) was used as an adjunctive treatment for severe pernicious anaemia in a patient who refused blood transfusions.

What They Found

A 35-year-old patient with severe pernicious anaemia and a haemoglobin level of 26 g/L, who declined blood transfusions, received hyperbaric oxygen therapy. The HBO therapy was used as an adjunctive treatment, implying it helped manage her severe anaemia in the absence of transfusion.

Canadian Relevance

There is no direct Canadian connection mentioned in this study.

Study Limitations

The primary limitation of this study is that it is a single case report, which limits the generalizability of its findings.